FMC Corp to Acquire BioPhero ApS - M&A Call Transcript

Jun 30, 2022 / 01:00PM GMT
Operator

Hello, and welcome to today's BioPhero acquisition conference call. My name is Elliot, and I will be coordinating your call today. (Operator Instructions) I would now like to turn the call over to Zack Zaki, Director of Investor Relations. The floor is yours. Please go ahead.

Abizar Zaki - FMC Corporation - IR Director

Good morning, everyone, and thank you for participating in today's call to discuss FMC Corporation's agreement to acquire BioPhero. Joining me today are Mark Douglas, President and Chief Executive Officer; Andrew Sandifer, Executive Vice President and Chief Financial Officer; and Dr. Kathleen Shelton, Executive Vice President and Chief Technology Officer.

Mark will begin with highlights of the acquisition, introduce the current pheromone market and provide a view of the sizable market potential for BioPhero's unique technology. Following the prepared remarks, we will take questions. Yesterday's press release and today's slide presentation is available on our website, and the prepared remarks from today's discussion will be made available

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot